Department of Psychiatry and Behavioral Sciences, Duke Clinical Research Institute, Duke University School of Medicine, Durham, NC 27705, USA.
J Sex Med. 2013 Feb;10 Suppl 1(0 1):43-52. doi: 10.1111/j.1743-6109.2012.02995.x.
We describe the development and validation of the Patient-Reported Outcomes Measurement Information System(®) Sexual Function and Satisfaction (PROMIS(®) SexFS; National Institutes of Health) measures, version 1.0, for cancer populations.
To develop a customizable self-report measure of sexual function and satisfaction as part of the U.S. National Institutes of Health PROMIS Network.
Our multidisciplinary working group followed a comprehensive protocol for developing psychometrically robust patient-reported outcome measures including qualitative (scale development) and quantitative (psychometric evaluation) development. We performed an extensive literature review, conducted 16 focus groups with cancer patients and multiple discussions with clinicians, and evaluated candidate items in cognitive testing with patients. We administered items to 819 cancer patients. Items were calibrated using item-response theory and evaluated for reliability and validity.
The PROMIS SexFS measures, version 1.0, include 81 items in 11 domains: Interest in Sexual Activity, Lubrication, Vaginal Discomfort, Erectile Function, Global Satisfaction with Sex Life, Orgasm, Anal Discomfort, Therapeutic Aids, Sexual Activities, Interfering Factors, and Screener Questions.
In addition to content validity (patients indicate that items cover important aspects of their experiences) and face validity (patients indicate that items measure sexual function and satisfaction), the measure shows evidence for discriminant validity (domains discriminate between groups expected to be different) and convergent validity (strong correlations between scores on PROMIS and scores on conceptually similar older measures of sexual function), as well as favorable test-retest reliability among people not expected to change (interclass correlations from two administrations of the instrument, 1 month apart).
The PROMIS SexFS offers researchers a reliable and valid set of tools to measure self-reported sexual function and satisfaction among diverse men and women. The measures are customizable; researchers can select the relevant domains and items comprising those domains for their study.
我们描述了患者报告的结局测量信息系统(®)性功能和满意度(PROMIS(®)性 FS;美国国立卫生研究院)测量工具,版本 1.0 的开发和验证,适用于癌症患者。
作为美国国立卫生研究院 PROMIS 网络的一部分,开发一种可定制的性功能和满意度自我报告测量工具。
我们的多学科工作组遵循了一个全面的协议,用于开发心理测量学上可靠的患者报告的结果测量工具,包括定性(量表开发)和定量(心理测量评估)开发。我们进行了广泛的文献回顾,对癌症患者进行了 16 个焦点小组讨论,并与临床医生进行了多次讨论,还对患者进行了认知测试来评估候选项目。我们对 819 名癌症患者进行了测试。使用项目反应理论对项目进行校准,并评估其可靠性和有效性。
PROMIS SexFS 测量工具,版本 1.0,包括 11 个领域的 81 个项目:对性活动的兴趣、润滑、阴道不适、勃起功能、对性生活的总体满意度、性高潮、肛门不适、治疗辅助、性活动、干扰因素和筛选问题。
除了内容有效性(患者表示项目涵盖了他们体验的重要方面)和表面有效性(患者表示项目衡量了性功能和满意度)之外,该测量工具还具有区分有效性(领域区分预期不同的群体)和收敛有效性(PROMIS 分数与概念上相似的旧性功能测量分数之间的强相关性),以及在预期不会发生变化的人群中具有良好的重测信度(两次测试之间的仪器的组内相关系数,相隔一个月)。
PROMIS SexFS 为研究人员提供了一组可靠和有效的工具,用于衡量不同男性和女性的自我报告的性功能和满意度。这些测量工具是可定制的;研究人员可以为他们的研究选择相关的领域和包含这些领域的项目。